Curanex Pharmaceuticals Inc
CURX
$0.44
$0.037.48%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 374.70% | -58.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1,548.70% | -58.04% | |||
| Operating Income | -1,548.70% | 58.04% | |||
| Income Before Tax | -1,482.26% | 56.18% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1,482.26% | 56.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1,482.26% | 56.18% | |||
| EBIT | -1,548.70% | 58.04% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -1,392.00% | 56.14% | |||
| Normalized Basic EPS | -1,356.25% | 55.56% | |||
| EPS Diluted | -1,392.00% | 56.14% | |||
| Normalized Diluted EPS | -1,356.25% | 55.56% | |||
| Average Basic Shares Outstanding | 6.67% | 0.00% | |||
| Average Diluted Shares Outstanding | 6.67% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||